Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Abstract
Pharmacists are health care professionals who are actively involved in identifying and solving drug-related problems (DRPs) in neoplasm patients. However, the effectiveness of pharmaceutical services at outpatient clinic for neoplasm patients have not been reported in China. This study aims to describe and investigate the impacts of pharmacists-managed oncology outpatient clinic on ambulatory neoplasm patients. We performed a descriptive, prospective study from June 6, 2018 to June 6, 2020. Firstly, we established a pharmacists-managed oncology outpatient clinic and a Pharmacists Work System of Medication Therapy Management (MTM) software with the cooperation of oncologists, pharmacists and software engineers in 2018. Subjects were neoplasm patients who visited the pharmacists-managed outpatient clinic. The pharmacists performed a comprehensive assessment of the patient’s medication and made planned interventions based on the DRPs identified. A total of 215 eligible patients with 707 visits were enrolled and recorded in the MTM software. A total of 316 DRPs (1.47 per patient) were identified. Adverse reactions, non-adherence, untreated indication, and drug interactions were the leading DRPs. 261 (82.6%) of the identified DRPs had been confirmed as resolved and 104 (78.2%) of adverse reactions were improved following pharmacist interventions and 2 to 3 course follow-up. Of the 382 planned interventions, 345 (90.3%) were accepted by patients or physicians. This is the first pharmacists-managed oncology outpatient clinic to describe the type of DRPs in neoplasm patients and evaluate the effectiveness of pharmacist interventions in China. Pharmacist interventions were efficacious in resolving DRPs and improving adverse reactions. We confirmed that pharmacists have an important role in ambulatory neoplasm patients care.Keywords
This publication has 26 references indexed in Scilit:
- Medication adherence to oral cancer therapy: The promising role of the pharmacistJournal of Oncology Pharmacy Practice, 2014
- Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinicAsia-Pacific Journal of Clinical Oncology, 2014
- Comprehensive Geriatric Assessment in OncologyPublished by S. Karger AG ,2013
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012
- Underprescription of Beneficial Medicines in Older PeopleDrugs & Aging, 2012
- Tenets for Developing Quality Measures for Ambulatory Clinical Pharmacy ServicesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?Drugs & Aging, 2009
- Potential for drug interactions in hospitalized cancer patientsCancer Chemotherapy and Pharmacology, 2005
- From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer careSupportive Care in Cancer, 2004
- Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applicationsBritish Journal of Clinical Pharmacology, 2003